Nexium Jury Told Drug Cos. Wheeled-And-Dealed With Patent
Nexium buyers pursuing a pay-for-delay case against AstraZeneca PLC and two generic-drug makers told a Boston federal jury on Tuesday that the pharmaceutical companies were trying to game the patent system...To view the full article, register now.
Already a subscriber? Click here to view full article